Correlation Between Sk Biopharmaceutica and HLB Power
Can any of the company-specific risk be diversified away by investing in both Sk Biopharmaceutica and HLB Power at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sk Biopharmaceutica and HLB Power into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sk Biopharmaceuticals Co and HLB Power Co, you can compare the effects of market volatilities on Sk Biopharmaceutica and HLB Power and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sk Biopharmaceutica with a short position of HLB Power. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sk Biopharmaceutica and HLB Power.
Diversification Opportunities for Sk Biopharmaceutica and HLB Power
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between 326030 and HLB is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and HLB Power Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLB Power and Sk Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sk Biopharmaceuticals Co are associated (or correlated) with HLB Power. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLB Power has no effect on the direction of Sk Biopharmaceutica i.e., Sk Biopharmaceutica and HLB Power go up and down completely randomly.
Pair Corralation between Sk Biopharmaceutica and HLB Power
Assuming the 90 days trading horizon Sk Biopharmaceuticals Co is expected to generate 0.52 times more return on investment than HLB Power. However, Sk Biopharmaceuticals Co is 1.92 times less risky than HLB Power. It trades about 0.01 of its potential returns per unit of risk. HLB Power Co is currently generating about -0.17 per unit of risk. If you would invest 10,470,000 in Sk Biopharmaceuticals Co on December 22, 2024 and sell it today you would lose (20,000) from holding Sk Biopharmaceuticals Co or give up 0.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sk Biopharmaceuticals Co vs. HLB Power Co
Performance |
Timeline |
Sk Biopharmaceuticals |
HLB Power |
Sk Biopharmaceutica and HLB Power Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sk Biopharmaceutica and HLB Power
The main advantage of trading using opposite Sk Biopharmaceutica and HLB Power positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sk Biopharmaceutica position performs unexpectedly, HLB Power can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLB Power will offset losses from the drop in HLB Power's long position.Sk Biopharmaceutica vs. Ni Steel | Sk Biopharmaceutica vs. Samwon Steel | Sk Biopharmaceutica vs. Hyundai BNG Steel | Sk Biopharmaceutica vs. Husteel |
HLB Power vs. Orbitech Co | HLB Power vs. Handok Clean Tech | HLB Power vs. Taegu Broadcasting | HLB Power vs. SS TECH |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |